CanSino Biologics Inc - Asset Resilience Ratio

Latest as of December 2025: 19.62%

CanSino Biologics Inc (CJH) has an Asset Resilience Ratio of 19.62% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€1.41 Billion

≈ $1.65 Billion USD Cash + Short-term Investments

Total Assets

€7.18 Billion

≈ $8.39 Billion USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how CanSino Biologics Inc's Asset Resilience Ratio has changed over time. Check strategic asset allocation of CanSino Biologics Inc to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down CanSino Biologics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is CanSino Biologics Inc worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€1.41 Billion	19.62%
Total Liquid Assets	€1.41 Billion	19.62%

Asset Resilience Insights

Good Liquidity Position: CanSino Biologics Inc maintains a healthy 19.62% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

CanSino Biologics Inc Industry Peers by Asset Resilience Ratio

Compare CanSino Biologics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for CanSino Biologics Inc (2016–2025)

The table below shows the annual Asset Resilience Ratio data for CanSino Biologics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	19.62%	€1.41 Billion ≈ $1.65 Billion	€7.18 Billion ≈ $8.39 Billion	-0.97pp
2024-12-31	20.60%	€1.64 Billion ≈ $1.92 Billion	€7.96 Billion ≈ $9.30 Billion	-1.65pp
2023-12-31	22.25%	€2.07 Billion ≈ $2.42 Billion	€9.32 Billion ≈ $10.89 Billion	-0.01pp
2022-12-31	22.25%	€2.55 Billion ≈ $2.98 Billion	€11.47 Billion ≈ $13.41 Billion	+2.66pp
2021-12-31	19.59%	€2.33 Billion ≈ $2.72 Billion	€11.87 Billion ≈ $13.88 Billion	+9.71pp
2020-12-31	9.88%	€666.64 Million ≈ $779.37 Million	€6.75 Billion ≈ $7.89 Billion	-21.07pp
2019-12-31	30.95%	€552.34 Million ≈ $645.75 Million	€1.78 Billion ≈ $2.09 Billion	+13.36pp
2018-12-31	17.59%	€140.00 Million ≈ $163.67 Million	€795.88 Million ≈ $930.46 Million	-28.88pp
2017-12-31	46.47%	€402.64 Million ≈ $470.72 Million	€866.36 Million ≈ $1.01 Billion	+17.66pp
2016-12-31	28.82%	€94.00 Million ≈ $109.90 Million	€326.17 Million ≈ $381.33 Million	--

pp = percentage points

About CanSino Biologics Inc

F:CJH Germany Drug Manufacturers - Specialty & Generic

Market Cap

$390.87 Million

€334.33 Million EUR

Market Cap Rank

#13426 Global

#1393 in Germany

Share Price

€2.52

Change (1 day)

+0.00%

52-Week Range

€2.28 - €5.95

All Time High

€45.99